The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
September 27th 2024
An oral session Friday at the International Myeloma Society 21st Annual Meeting & Exposition offered updates for the TRIMM-2 and RedirecTT-1 trials.
September 27th 2024
Dr Timothy Murphy Discusses Successfully Implementing Biosimilars Into Community Cancer Practice
October 28th 2022Having a plan in place to educate providers and the pharmacy team has contributed to the success that Rocky Mountain Cancer Centers (RMCC) has had with rapidly implementing biosimilars, said Timothy Murphy, MD, medical oncologist/hematologist with RMCC.
Watch
Are NK-Cell–Based Treatments the Next Approach in Immuno-Oncology?
October 25th 2022Highlighting their ability to quickly destroy malignant cells without antigen specificity, natural killer (NK) cells have been identified as an opportunity for use, particularly in cases where T cells are not effective.
Read More
Potential Risk Factors Identified for RRT Among Patients With PH
October 24th 2022According to the study authors, acute decompensated pulmonary hypertension (PH) is often accompanied by systemic congestion and right ventricular flow output, and because PH can be accompanied by acute kidney injury, renal replacement therapy (RRT) may be necessary.
Read More
Identifying ASCT-Ineligible Patients Who Could Benefit From CAR T-Cell Treatment
October 22nd 2022Data suggest that the technology may be an option for patients who are ineligible for autologous stem cell transplantation (ASCT) based on certain patient characteristics, prior treatments, stem cell availability, or tumor chemosensitivity.
Read More
Syncope May Increase Vasoreactivity Among Pediatric Patients With PAH
October 19th 2022Although group 1 pulmonary arterial hypertension (PAH) with comorbid syncope has been linked to a poor prognosis among adults, this relationship remains uncertain in pediatric patients, prompting a new study.
Read More
Patients on Biologics for Severe Asthma Show Reduced Response to SARS-CoV-2 Vaccination
October 18th 2022Martin Runnström, MD, a fourth-year fellow at the Emory University School of Medicine, describes a study he presented at CHEST 2022 showing a reduced response to a 2-dose immunization series for SARS-CoV-2 among patients using biologics to treat severe asthma or atopic dermatitis.
Watch
Pulmonary Embolism Treatments Are Evolving, Says Dr Parth Rali
October 16th 2022There are several closely watched randomized trials examining catheter-directed therapies for acute pulmonary embolism, according to Parth Rali, MD, an associate professor of thoracic medicine and surgery at the Lewis Katz School of Medicine and director of the Temple University Health System Pulmonary Embolism Response Team.
Watch
Patients With Uncontrolled Asthma May Need to Be Considered for Triple Therapy, Posters Find
October 16th 2022One poster found patients with uncontrolled asthma had improved outcomes after escalating to triple therapy, while the other found a substantial portion of patients adherent to a dual therapy reported not having controlled asthma.
Read More